BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 26940270)

  • 1. Lymphoma Microenvironment and Immunotherapy.
    Xu ML; Fedoriw Y
    Surg Pathol Clin; 2016 Mar; 9(1):93-100. PubMed ID: 26940270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hide or defend, the two strategies of lymphoma immune evasion: potential implications for immunotherapy.
    de Charette M; Houot R
    Haematologica; 2018 Aug; 103(8):1256-1268. PubMed ID: 30006449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Engaging the Innate and Adaptive Antitumor Immune Response in Lymphoma.
    Csizmar CM; Ansell SM
    Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33804869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunotherapy in lymphoma.
    Ansell SM; Caligaris-Cappio F; Maloney DG
    Hematol Oncol; 2017 Jun; 35 Suppl 1():88-91. PubMed ID: 28591421
    [No Abstract]   [Full Text] [Related]  

  • 5. Molecular mechanisms of HLA class I-mediated immune evasion of human tumors and their role in resistance to immunotherapies.
    Seliger B
    HLA; 2016 Nov; 88(5):213-220. PubMed ID: 27659281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of immune evasion in breast cancer.
    Bates JP; Derakhshandeh R; Jones L; Webb TJ
    BMC Cancer; 2018 May; 18(1):556. PubMed ID: 29751789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting the tumor microenvironment by immunotherapy: part 2.
    Leibovici J; Itzhaki O; Huszar M; Sinai J
    Immunotherapy; 2011 Nov; 3(11):1385-408. PubMed ID: 22053888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The immune microenvironment in malignant lymphoma].
    Nishikori M
    Rinsho Ketsueki; 2019; 60(9):1229-1235. PubMed ID: 31597848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Development of novel immunotherapy targeting cancer immune evasion].
    Tamada K
    Gan To Kagaku Ryoho; 2014 Sep; 41(9):1062-5. PubMed ID: 25248888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor microenvironment (TME)-driven immune suppression in B cell malignancy.
    Nicholas NS; Apollonio B; Ramsay AG
    Biochim Biophys Acta; 2016 Mar; 1863(3):471-482. PubMed ID: 26554850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of tumor-induced T cell immune suppression and therapeutics to counter those effects.
    Hwang I; Nguyen N
    Arch Pharm Res; 2015 Aug; 38(8):1415-33. PubMed ID: 25634101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Innate and acquired immune surveillance in the postdissemination phase of metastasis.
    Gonzalez H; Robles I; Werb Z
    FEBS J; 2018 Feb; 285(4):654-664. PubMed ID: 29131550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genomic alterations underlying immune privilege in malignant lymphomas.
    Mottok A; Steidl C
    Curr Opin Hematol; 2015 Jul; 22(4):343-54. PubMed ID: 26049756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumour growth and immune evasion as targets for a new strategy in advanced cancer.
    Nicolini A; Ferrari P; Rossi G; Carpi A
    Endocr Relat Cancer; 2018 Nov; 25(11):R577–R604. PubMed ID: 30306784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting the Tumor Microenvironment of Leukemia and Lymphoma.
    Höpken UE; Rehm A
    Trends Cancer; 2019 Jun; 5(6):351-364. PubMed ID: 31208697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances in targeted therapy for malignant lymphoma.
    Wang L; Qin W; Huo YJ; Li X; Shi Q; Rasko JEJ; Janin A; Zhao WL
    Signal Transduct Target Ther; 2020 Mar; 5(1):15. PubMed ID: 32296035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microenvironmental abnormalities induced by viral cooperation: Impact on lymphomagenesis.
    De Paoli P; Carbone A
    Semin Cancer Biol; 2015 Oct; 34():70-80. PubMed ID: 25837157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Galectin 3 as a guardian of the tumor microenvironment.
    Ruvolo PP
    Biochim Biophys Acta; 2016 Mar; 1863(3):427-437. PubMed ID: 26264495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of m
    Wu C; Li L; Tang Q; Liao Q; Chen P; Guo C; Zeng Z; Xiong W
    Med Oncol; 2024 May; 41(6):159. PubMed ID: 38761335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The tumor microenvironment in follicular lymphoma.
    Yang ZZ; Ansell SM
    Clin Adv Hematol Oncol; 2012 Dec; 10(12):810-8. PubMed ID: 23271353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.